MBP
Click for more information
3.23% 3.0¢ metabolic pharmaceuticals limited

acv1 shows efficacy in trial, page-4

  1. jevalent
    5,260 Posts.
    lightbulb Created with Sketch. 242
    clock Created with Sketch.
    01/08/07
    22:43
    Post #: 2676216
    I have just had a communication from Dr. McIntosh confirming that the recent studies referred to in the abstract were animal studies. Not human.

    Still, any indication of efficacy, even in animal models, are welcome and tend to support expectations of success in the human trials.
    MBP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.